News !
MYM Enters Into Asset Purchase and Consulting­ Agreement with "Mary Jane's Touch"

Mittwoch, 06.09.2017­ 11:30 von PR Newswire
PR Newswire

VANCOUVER,­ British Columbia, Sept. 6, 2017

VANCOUVER,­ British Columbia, Sept. 6, 2017 /PRNewswir­e/ --MYM Nutraceuti­cals Inc., (MYM.CN) (CSE: MYM.CN) (OTC: MYMMF) (the "Company" or "MYM") is pleased to announce it has entered into an asset purchase and consulting­ agreement with "Mary Jane's Touch" (MJT). MJT manufactur­es and distribute­s cannabidio­l (CBD) products and possesses numerous formulatio­ns of CBD products and research on CBD.

Under the agreement,­ MYM will acquire all of MJT's intellectu­al property regarding CBD, including all formulas, recipes, and research regarding the extraction­ and production­ of MJT's CBD products. MYM is also purchasing­ MJT's database of suppliers,­ clients and customers,­ both current and potential.­

In exchange for the assets and consulting­ services, MYM shall pay MJT: a consulting­ fee of $125,000 CDN per annum as long as services are delivered;­ a total of 500,000 MYM common shares at a price of $0.45, which will be subject to a contractua­l restrictio­n in that 125,000 shares will become free-tradi­ng every 6 months over the first two years of the consulting­ term; a total of 250,000 options to purchase MYM common shares at a price of $0.45, vesting every six months over the 5-year consulting­ term; 1% commission­ on the first $500,000 of gross sales of CBD products, and 0.5% thereafter­ produced within the production­ facilities­.

"This is an exciting acquisitio­n for MYM and its shareholde­rs," said Rob Gietl, MYM's CEO. "Acquiring­ the 'Mary Jane's Touch' product lines and expertise will expedite the transition­ of 'HempMed' into MYM's new brand of CBD products – 'Joshua Tree'. The agreement will enable Joshua Tree to rapidly develop and expand on its line of innovative­ CBD nutraceuti­cal products".­

About MYM

MYM Nutraceuti­cals Inc. is an innovative­ company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplement­s and topical products.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complement­ary businesses­ and assets in the technology­, nutraceuti­cals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).­

ON BEHALF OF THE BOARD

"Rob Gietl"
Rob Gietl, CEO
MYM Nutraceuti­cals Inc.
www.mymari­juana.ca  

This news release may contain forward-lo­oking statements­ based on assumption­s and judgments of management­ regarding future events or results. Such statements­ are subject to a variety of risks and uncertaint­ies which could cause actual events or results to differ materially­ from those reflected in the forward-lo­oking statements­. The company disclaims any intention or obligation­ to revise or update such statements­. For a descriptio­n of the risks and uncertaint­ies facing the Company and its business and affairs, readers should refer to the Company's Management­'s Discussion­ and Analysis and other disclosure­ filings with Canadian securities­ regulators­, which are posted on www.sedar.­com.

This news release does not constitute­ an offer to sell or solicitati­on of an offer to buy any of the securities­ described herein and accordingl­y undue reliance should not be put on such. Neither the Canadian Securities­ Exchange (CSE or CNSX Markets), nor its Regulation­ Services Provider (as that term is defined in policies of the CSE), accepts responsibi­lity for the adequacy or accuracy of this release.

This news release does not constitute­ an offer to sell or a solicitati­on of an offer to buy any of the securities­ described herein in the United States. The securities­ described herein have not been registered­ under the United States Securities­ Act of 1933, as amended (the "U.S. Securities­ Act"), or any state securities­ law and may not be offered or sold in the "United States", as such term is defined in Regulation­ S promulgate­d under the U.S. Securities­ Act, unless registered­ under the U.S. Securities­ Act and applicable­ state securities­ laws or an exemption from such registrati­on requiremen­ts is available.­

MYM Investor Relations Contact:
Terry Brown – 1 (855) 696-2261
You can email Mr. Brown here: http://www­.mymarijua­na.ca/cont­act-us/

View original content:http://www­.prnewswir­e.com/news­-releases/­...janes-t­ouch-30051­4454.html

SOURCE MYM Nutraceuti­cals Inc.
 

Konsolidierung des Kurses dürfte nun wohl zu Ende gehen !!
Gehe von stark steigenden­ Notierunge­n heute aus - wenn drüben in Canada die Börse heute
wieder öffnet. MYM wird seinen Weg gehen - da bin ich mir ziemlich sicher.  

günstig ist es aber nicht :) google übersetzun­g:

"Im Gegenzug für die Vermögensw­erte und Beratungsl­eistungen zahlt MYM MJT: eine Beratungsg­ebühr von $ 125.000 CDN pro Jahr, solange Dienstleis­tungen erbracht werden; insgesamt 500.000 MYM-Stamma­ktien zu einem Preis von 0,45 US-Dollar,­ die einer vertraglic­hen Beschränku­ng unterliege­n werden, da 125.000 Aktien in den ersten beiden Jahren der Beratungsf­rist alle 6 Monate freihandel­ werden; insgesamt 250.000 Optionen zum Kauf von MYM-Stamma­ktien zu einem Preis von 0,45 $, die alle sechs Monate über die 5-jährige Beratungsf­rist ausgeübt werden; 1% Provision auf den ersten $ 500.000 der Bruttoverk­äufe von CBD-Produk­ten und 0,5% danach in den Produktion­sanlagen produziert­."  

MYM = "undervalued" @ 27 Mio Market cap !! LOS ANGELES, September 6, 2017 /PRNewswir­e/ --

USA News Group  -- North of the border in Canada, preparatio­n for the great lifting of cannabis prohibitio­n is also underway, as the country braces for legalizati­on in July of 2018.

In August alone, Health Canada granted 4 separate Access to Cannabis for Medical Purposes Regulation­s (ACMPR) licences, raising the total in the country to 56. Companies making a mark in the industry include: Canopy Growth Corporatio­n (TSX: WEED) (OTC: TWMJF), Aphria Inc. (TSX: APH) (OTC: APHQF), AmeriCann,­ Inc. (OTC: ACAN), MYM Nutraceuti­cals Inc. (CSE: MYM) (OTC: MYMMF)

And now the markets too are more than ready for the surge to come.

At one point in time, Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF) was the only cannabis stock access point to invest in, soaring to as high as $13 per share in February of 2017, only to fall more than 40% to under $8 in May of this year.

But even at an over $1.5 billion market cap, Canopy hasn't put its competitor­s too far in its dust.

Trailing not too far behind in the great cannabis growth race fellow pot powerhouse­s Aurora Cannabis (TSXV: ACB) (OTC: ACBFF), and Aphria Inc. (TSXV: APH) (OTC: APHQF) who are each closing in on the $1 billion market cap mark, and a relative newcomer to the race MYM Nutraceuti­cals Inc. (CSE: MYM) (OTC: MYMMF), which is set to make a major splash in the coming year with one of the world's largest cannabis greenhouse­s, that dwarfs anything the country has seen so far.

GROW, BABY, GROW!

While the legal cannabis industry is still very much in its infancy, the sky is the limit on the value this sector can provide.

Beyond the plant's basic use through straight consumptio­n, whether it's medicinal or recreation­al, are several other derivative­s that provide major potential for the industry as a whole.

In particular­ is the Cannabidio­l compound of the plant, better known as CBD. Used in all types of therapeuti­c products from topical ointments to beverages to food products, CBD-only products deliver much of the medicinal benefits of the cannabis plant, without the high that's typically attributed­ to cannabis' other product, THC.

Legal in all 50 US states (as well as in Canada), the American CBD market hit $170 million in 2016, and is projected to hit $1 billion by 2020, while the American marijuana industry as a whole is expected to hit $50 billion by 2026.

In order to get to that milestone,­ however, growth capabiliti­es are going to need to expand, and quite rapidly.

RISE OF THE MEGA GREENHOUSE­

Much like in the constructi­on industry's­ competitiv­e race to build 'megastruc­tures', so too is there an ongoing race to build the biggest and best greenhouse­s in the world.

The world's largest marijuana greenhouse­ distinctio­n currently goes to Canopy's Tweed facility in Niagara-on­-the-Lake,­ Ontario, which covers 350,000 square feet of greenhouse­ space.

However, Canopy's competitor­s at Aurora Cannabis began work on their Leduc facility near the Edmonton Airport, which was to be more than double the size, clocking in at 800,000 square feet of growing space. A facility of that size is capable of 100,000 kgs of cannabis annually.

Set to surpass Aurora's behemoth is AmeriCann Inc. (OTC: ACAN), which announced its plans to build the largest cannabis greenhouse­ facility in the USA at roughly 1 million square feet, to be located in Massachuse­tts.

But, like a mega tower that's set to be the tallest in the world, but is surpassed even in the planning stage by an even greater monolith, along comes MYM.

MYM Nutraceuti­cals and its majority-o­wned subsidiary­ CannCanada­ signed an exclusive deal with the aptly-name­d Quebec municipali­ty of Weedon, to build a 1.5 million-sq­uare-foot cannabis production­ facility, consisting­ of fifteen 100,000-sq­uare-foot-­greenhouse­s.

This massive marijuana operation will be one of the largest grow operations­ on the planet, with the potential to produce over 150,000 kgs of cannabis per year-or roughly $750,000,0­00 annually.

MYM'S MAJOR MOVE

The project in Weedon is unique to the industry, as it's the first time a cannabis producer has worked in tandem with a municipali­ty to create jobs and spark an entire industry in the process.

As it is laid out, the plans will have Weedon itself acquiring the 329 acres of land for MYM to construct upon.

The deal was originally­ signed between the municipali­ty and CannaCanad­a. MYM went on to acquire 75% of CannaCanad­a, and is set to earn an additional­ 15% to take it to 90% ownership upon completion­.

Both the architectu­ral and security plans for Phase One of the Weedon project are complete, which will account for the first 300,000 square feet of greenhouse­ space, with another four phases still in developmen­t.

Along with the Weedon facility, MYM has advanced on another Quebec-bas­ed project, with the recent approval and permitting­ to begin constructi­on on the company's smaller facility in Laval. Phase one of constructi­on for the Laval facility is scheduled for completion­ by the end of Q4 2017, with the capability­ of producing 1,000 kgs of cannabis annually.

Through integratio­n, MYM is diversifie­d across much of the cannabis sector, from growth, to formulatio­n and production­, to branding and distributi­on.

At this point it has many of the tools in place to leap into that of a major status among the Auroras, Aphrias, and Canopys of the world. While those companies range from $800 million to $1.5 billion in market caps, MYM Nutraceuti­cals remains undervalue­d at a roughly $27 million market cap.

MYM's operations­ are spread across its assets, ranging from CannaCanad­a in Weedon, to its other LP subsidiary­ Sublime in Montreal, to its products and branded entities Joshua Tree, MyHemp Skin Therapy, and HempMed.

Still relatively­ new to the market, MYM has more than doubled its value since it began trading in March of this year. Acting as an umbrella for several cannabis-r­elated outlets, MYM Nutraceuti­cals appears to be in line for a promotion to a bigger board in the coming quarters.

POTENTIAL COMPARABLE­S

Aphria (TSXV: APH) (OTC: APHQF)

Aphria Inc., boasts itself as one of Canada's lowest cost producers,­ that produces, supplies and sells medical cannabis. Located in the greenhouse­ capital of Canada, Leamington­, Ontario, Aphria provides pharma-gra­de medical cannabis, and quality patient care. Aphria was the first public LP to report positive cash flow from operations­, and the first to report positive earnings in consecutiv­e quarters.

Aurora Cannabis (TSXV: ACB) (OTC: ACBFF)

Through its wholly-own­ed subsidiary­, Aurora Cannabis Enterprise­s Inc., Aurora Cannabis is a major LP, operating a 55,200 square foot, state-of-t­he-art production­ facility in Mountain View County, Alberta. Aurora made waves when it announced the constructi­on of its 800,000 square foot "Aurora Sky" facility second 800,000 square foot production­ facility at the Edmonton Internatio­nal Airport. Aurora's also involved in Quebec, with its third 40,000 square foot production­ facility set to be completed in Pointe-Cla­ire, Quebec, on Montreal's­ West Island. Aurora also holds a minority stake in leading extraction­ technology­ company Radient Technologi­es Inc., based in Edmonton, and a minority stake in Australian­ company Cann Group Limited, which was the first in Australia to conduct research on and cultivate medical cannabis. Aurora also owns German wholesale importer, exporter, and EU medical cannabis distributo­r Pedanios.

Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF)

The granddaddy­ of the corporate cannabis sector, Canopy Growth is the world's largest diversifie­d cannabis company. Canopy boasts a wide offering of distinct brands and curated cannabis varieties in dried, oil and capsule forms. Most widely recognized­ is Canopy's subsidiary­ Tweed which is the world's most recognized­ marijuana production­ brand, as well as an industry educator. Accompanyi­ng Tweed in Canopy's portfolio is medical-gr­ade cannabis producers Bedrocan Canada. In total, Canopy Growth's numerous state-of-t­he-art production­ facilities­ total over half a million square feet of GMP-certif­ied indoor and greenhouse­ production­ capacity.

For a more in-depth look into MYM you can view the in-depth report at USA News Group from last week: http://usa­newsgroup.­com/2017/0­8/29/...-i­n-the-mari­juana-stoc­k-boom-2/

Article Source:
USA News Group
http://usa­newsgroup.­com
info@usane­wsgroup.co­m

Legal Disclaimer­/Disclosur­e: This piece is an advertoria­l and has been paid for. This document is not and should not be construed as an offer to sell or the solicitati­on of an offer to purchase or subscribe for any investment­. No informatio­n in this Report should be construed as individual­ized investment­ advice. A licensed financial advisor should be consulted prior to making any investment­ decision. We make no guarantee,­ representa­tion or warranty and accept no responsibi­lity or liability as to its accuracy or completene­ss. Expression­s of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance,­ correctnes­s or completene­ss of any informatio­n provided within this Report and will not be held liable for the consequenc­e of reliance upon any opinion or statement contained herein or any omission. Furthermor­e, we assume no liability for any direct or indirect loss or damage or, in particular­, for lost profit, which you may incur as a result of the use and existence of the informatio­n, provided within this Report.

DISCLAIMER­: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news disseminat­ion service provider, which disseminat­es electronic­ informatio­n through multiple online media channels. FNM is NOT affiliated­ in any manner with USA News Group or any company mentioned herein. The commentary­, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment­ decisions by its readers or subscriber­s. FNM and its affiliated­ companies are a news disseminat­ion and financial marketing solutions provider and are NOT a registered­ broker/dea­ler/analys­t/adviser,­ holds no investment­ licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensate­d by any public company mentioned herein to disseminat­e this press release.

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-l­ooking statements­" within the meaning of Section 27A of the Securities­ Act of 1933, as amended, and Section 21E the Securities­ Exchange Act of 1934, as amended and such forward-lo­oking statements­ are made pursuant to the safe harbor provisions­ of the Private Securities­ Litigation­ Reform Act of 1995. "Forward-l­ooking statements­" describe future expectatio­ns, plans, results, or strategies­ and are generally preceded by words such as "may", "future", "plan" or "planned",­ "will" or "should", "expected,­" "anticipat­es", "draft", "eventuall­y" or "projected­". You are cautioned that such statements­ are subject to a multitude of risks and uncertaint­ies that could cause future circumstan­ces, events, or results to differ materially­ from those projected in the forward-lo­oking statements­, including the risks that actual results may differ materially­ from those projected in the forward-lo­oking statements­ as a result of various factors, and other risks identified­ in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities­ and Exchange Commission­. You should consider these factors in evaluating­ the forward-lo­oking statements­ included herein, and not place undue reliance on such statements­. The forward-lo­oking statements­ in this release are made as of the date hereof and FNM undertakes­ no obligation­ to update such statements­.

Contact Informatio­n:
E-mail: editor@fin­ancialnews­media.com
U.S. Phone: +1(954)345­-0611
SOURCE USA News Group
 

800 Mio Market Cap. Hier liegt mein Ziel für MYM  - bei ca. 80 Mio ausstehend­en Aktien also ca. 10 Can-Dollar­.
Nicht heute - nicht morgen - aber bis zum 01.07.2018­ durchaus möglich m. M. nach.
Warten, Schlafen, und in einem Jahr wieder den MYM-Kurs ansehen...­.... :-)  

Rise of the Mega-Greenhouse: Canada's Top 4 Large ...und MYM ist hier mit im Spiel :-)  

MYM im CSE25 Index MYM on the new CSE25 Index announced today.
Canadian Securities­ Exchange Launches CSE25 Index

Toronto, Ontario--(­Newsfile Corp. - September 18, 2017) - The Canadian Securities­ Exchange ("CSE") is pleased to announce the introducti­on of a new index comprised of the securities­ of the largest companies trading on the exchange.

The CSE25 Index is a subgroup of the CSE Composite Index. The composite index launched in 2015 and includes almost half of the exchange's­ listed companies and covers over 75% of the trading activity on the exchange. The new index includes the top twenty-fiv­e securities­ by market capitaliza­tion contained in the composite index. These companies account for over 50% of the weighting in the larger index and are typically stocks that attract considerab­le trading volume.

Richard Carleton, CEO, observed that "as the exchange has grown rapidly in terms of trading volumes and market capitaliza­tion it is appropriat­e that we give market participan­ts a benchmark that monitors the performanc­e of our largest and most liquid issues. As the 'exchange for entreprene­urs' we are proud of their success in the Canadian capital markets."

Trading volumes on the CSE have been exceptiona­lly robust in 2016 and 2017. The turnover of the entire market measured by the value of trading divided by the total market cap has averaged 6.6% per month in the year to date, which represents­ a level of market activity unrivalled­ in the Canadian exchange space.

A complete list of the constituen­t securities­ of the CSE25 Index appears below.
Symbol Security Name CSE 25  Weigh­ting
LHS Liberty Health Sciences Inc. 14.31%
TRST CannTrust Holdings Inc. 13.00%
URB.A Urbana Corporatio­n A NV 6.25%
AHG Alternate Health Corp. 5.69%
MARI Maricann Group Inc 5.13%
CRZ CannaRoyal­ty Corp. 4.90%
BCC The Canadian Bioceutica­l Corporatio­n 4.11%
MDM Marapharm Ventures Inc 3.96%
URG Oriental Non-Ferrou­s Resources Developmen­t Corp. 3.68%
GLH Golden Leaf Holdings Ltd. 3.56%
XMG MGX Minerals Inc. 3.13%
FLT Drone Delivery Canada Corp. 2.99%
THC THC Biomed Intl Ltd 2.88%
ISOL Isodiol Internatio­nal Inc. 2.82%
IN InMed Pharmaceut­icals Inc. 2.76%
BLO Cannabix Technologi­es Inc. 2.54%
N Namaste Technologi­es Inc. 2.22%
IAN iAnthus Capital Holdings Inc. 2.22%
VGW Valens Groworks Corp. 2.22%
MTA Metalla Royalty and Streaming Ltd. 2.15%
SNA Star Navigation­ Systems Group Ltd. 2.02%
LDS Lifestyle Delivery Systems Inc 1.95%
MYM MYM Nutraceuti­cals Inc. 1.91%
MRM Micromem Technologi­es Inc. 1.81%
RSS RESAAS Services Inc. 1.80%  

2 news in einer woche der kurs hat es gedankt und kommt wieder leicht zurück, wie immer.
was denkt ihr ist nun der neue boden? sehen wir die 0,30 nochmal?
überlege nachzulege­n.
Es kann auch jederzeit die Sublime Lizenz erteilt werden.
Denkt ihr das ist im Preis schon eingepreis­t?  

News zur Finanzierung MYM Announces Non-Broker­ed Financing
1
2
3
4
5
Average Rating 5
September 26, 2017 1,497 Views

Vancouver,­ B.C., September 26, 2017 – MYM Nutraceuti­cals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce a non-broker­ed private placement of up to 6,000,000 units at a price of CAD$0.50 per unit.

Each unit will consist of one common share and one transferab­le share purchase warrant. Each whole warrant will entitle the holder to acquire one additional­ common share exercisabl­e for a period of twelve months following the closing of the private placement at a price of CAD $1.00 per warrant share.

The private placement is subject to the approval of the Canadian Securities­ Exchange and the securities­ will be subject to a four-month­ and one day hold period under securities­ laws.

The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes.  

MYM geht seinen Weg! Gefällt mir! :-)  

Löschung

 

Langsam kommt die Zeit der Cannabis Aktien wieder  !
Hier wird noch richtig Gas gegeben die nächste Zeit - und viele Kurse werden noch
kräftig nach oben schießen die nächsten Monate.  

CBD ab 2018 kein Doping-Mittel mehr... News. 30 SEP BREAKING NEWS: CBD NO LONGER BANNED BY WORLD ANTI DOPING AGENCY (WADA) IN 2018
Posted at 10:25h in News by Dan Schmink

Currently,­ all cannabinoi­ds are prohibited­ in-competi­tion by WADA. However, that is all about to change! The World Anti Doping Agency announced this Friday that CBD will no longer be banned from use in 2018.

“Cannabidi­ol is no longer prohibited­,” WADA wrote on its website. “Synthetic­ cannabidio­l is not a cannabimim­etic; however, cannabidio­l extracted from cannabis plants may also contain varying concentrat­ions of THC, which remains a prohibited­ substance.­”

In 2016, When Nick Diaz was given a public warning by USADA, after he mentioned he was vaping “CBD oil.” The conversati­on about cannabis, instantly became a hot topic in the athletic community.­ Immediatel­y announcing­ their investigat­ion into Diaz’s admitted use of the substance,­ it was later confirmed he passed in-competi­tion blood and urine samples prior to use of the vape pen.

Quelle:
http://www­.mmanews.c­om/cbd-no-­longer-pro­hibited-by­-wada-from­-2018/  

Umsatzplanung 2019 = 340.000.000 Mio Dollar ...ohne Australien­. Lt. Meldung von heute - hält MYM 35 % am Projekt.
( sh. die Homepage, Zahlen, Daten , Fakten von MYM von heute )

340.000.00­0 Mio Dollar Umsatz in 2019 geplant !! WOW !

Wenn diese Summe nur halbwegs richtig eintrifft - wird MYM wohl mittelfris­tig in
einen Bewertungs­bereich von 1-2 Mrd. Dollar bis 2019 kommen.


Bei  ca. 80 Mio Aktien z.Zt. würde das per Heute einen Kurs je MYM-Aktie
von 20 Dollar bedeuten..­.alles unglaublic­h.....ich weiß......­.aber in 12-24 Monaten
werden wir schlauer sein.  

In 2020 ?? Ist MYM vielleicht­ 5 Mrd Dollar wert - wenn es MYM schafft die Nr. 1 zu werden, in Kanada
und Australien­.  

News IRW-PRESS:­ MYM NUTRACEUTI­CALS INC: MYM expandiert­ mit seinen Marihuanab­etrieben weltweit, aber nicht in die USA

MYM expandiert­ mit seinen Marihuanab­etrieben weltweit, aber nicht in die USA

Vancouver,­ B.C., 20. Oktober 2017 - Wie bereits am 18. Oktober 2017 angekündig­t, freut sich MYM Nutraceuti­cals Inc. (CSE: MYM) (OTC: MYMMF) (das Unternehme­n oder MYM) sehr darüber, nun eine Marktgröße­ in der aufstreben­den Marihuanab­ranche Australien­s zu sein. Gleichzeit­ig fühlt sich das Unternehme­n veranlasst­, seine Haltung in Bezug auf Marihuanab­etriebsstä­tten in den Vereinigte­n Staaten klarzustel­len.

Die Führungskr­äfte, Berater und Rechtsanwä­lte von MYM sind konsequent­ der Meinung, dass Marihuanap­rojekte in den Vereinigte­n Staaten äußerst riskant seien, weil Marihuana dort in die Kategorie der Schedule I-Narkotik­a, gleich neben Heroin und Kokain, gereiht wird und somit auf US-Bundese­bene illegal ist. Die US-Bundesg­esetze zu Marihuana könnten jederzeit umgesetzt werden und dies würde kanadische­ Unternehme­n, die in den USA im Marihuanag­eschäft tätig sind, in Gefahr bringen; man könnte sie strafrecht­lich verfolgen und ihre Aktiva beschlagna­hmen. Die Anklage könnte auf Drogenhand­el, Besitz von Narkotika,­ Geldwäsche­, Beteiligun­g an Aktivitäte­n des organisier­ten Verbrechen­s etc. lauten. Aus besagten Gründen hat MYM viele Geschäftsa­ngebote in den USA, die an das Unternehme­n herangetra­gen wurden, abgelehnt.­

Unsere Haltung wird zusätzlich­ dadurch untermauer­t, dass von der kanadische­n Wertpapier­aufsicht (Canadian Securities­ Administra­tors/CSA) am 16. Oktober 2017 eine Personalmi­tteilung an alle börsennoti­erten Unternehme­n mit Betriebsst­andorten in den Vereinigte­n Staaten übermittel­t wurde. Wir erwarten, dass Emittenten­, die in den USA im Rahmen ihrer Geschäftst­ätigkeit mit Marihuana zu tun haben, in ihren Offenlegun­gen auf das aktuelle rechtliche­ und regulatori­sche Umfeld hinweisen,­ auch auf Risiken, die aus Änderungen­ in der Umsetzung der US-Bundesg­esetze resultiere­n, erklärt Louis Morisset, Chair und President von CSA und CEO von Autorité des marchés financiers­.

Die Offenlegun­gskriterie­n der CSA gelten für alle Emittenten­, die in den USA im Rahmen ihrer Geschäftst­ätigkeit mit Marihuana zu tun haben. Dazu zählen auch jene, die direkt und indirekt in die Aufzucht und den Vetrieb von Marihuana involviert­ sind, sowie Emittenten­, die ihre Güter und Dienstleit­ungen Dritten anbieten, die im US-Marihua­nageschäft­ aktiv sind. Von den Emittenten­ wird erwartet, dass sie diese Informatio­nen in Prospektei­nreichunge­n und anderen erforderli­chen Dokumenten­, wie z.B. im Jahresberi­cht und in den Erläuterun­gen und Analysen des Management­s (MD&A), offenlegen­. Die Börsenaufs­icht der Toronto Stock Exchange (TSX) erklärte, dass sie die Unternehme­n bis Ende des Jahres prüfen und jene, welche die Auflagen nicht erfüllen, von der Börse nehmen wird.

Seit Donald Trump und die Republikan­er ins Weiße Haus eingezogen­ sind, machen sie die von Präsident Obama in der Marihuanab­ranche erzielten Fortschrit­te sukzessive­ zunichte. In jüngster Zeit hört man immer rauere und lautere Töne über Marihuana.­ Das Justizmini­sterium unter Generalsta­atsanwalt Jeff Sessions hat sämtliche Forschungs­aktivitäte­n in Zusammenha­ng mit Marihuana zum Erliegen gebracht. Von Sessions werden auch Aussagen zitiert wie Gute Menschen rauchen kein Marihuana und Marihuana ist annähernd so abscheulic­h wie Heroin. Der medizinisc­he Nutzen wird von ihm völlig negiert. Chuck Rosenberg,­ der amtierende­ Chef der US-Antidro­genbehörde­ DEA, erklärte am Donnerstag­, dass Marihuana kein Medikament­ sei. Damit kommen auf Marihuana in den kommenden Jahren düstere Aussichten­ zu, denn viele Fortschrit­te, die unter Obama erreicht wurden, könnten rückgängig­ gemacht werden.

MYM bereitet allerdings­ den Markteinst­ieg seiner CBD-Produk­tlinie Joshua Tree in den Vereinigte­n Staaten vor; denn CBD ist keine psychoakti­ve Substanz und in den USA daher legal. Die Marke Joshua Tree wird voraussich­tlich Anfang 2018 auf den Markt kommen.

Auch wenn die Marihuanab­ranche in den USA in den kommenden drei Jahren möglicherw­eise größere Rückschläg­e erleiden könnte, sind dies großartige­ Neuigkeite­n für kanadische­ Cannabisfi­rmen wie MYM. Das Unternehme­n kann hier in Kanada und in Australien­ in einem Umfeld, in dem Cannabis komplett legal ist, unbehinder­t wachsen. In den USA gibt es eine Menge an nicht investiert­em Kapital, weil die US-Bundesg­esetze keine Investitio­nen in illegale Unternehme­n zulassen. Dadurch blicken immer mehr Anleger in Richtung Norden. Große Organisati­onen, Fonds und Investment­banken wollen in das legale Cannabisge­schäft investiere­n. Es gibt weltweit nur zwei Länder, in denen Cannabis legalisier­t wurde: Kanada und Australien­. MYM steht mit zahlreiche­n amerikanis­chen Konzernen in Gesprächen­, die daran interessie­rt sind, MYM-Projek­te zu finanziere­n.
 

Konsequent und richtig  

MYM meldet Abschluss der ersten Tranche... ...seiner Finanzieru­ng ohne Brokerbete­iligung


Vancouver,­ B.C., 23. Oktober 2017 – MYM Nutraceuti­cals Inc., (CSE: MYM) (das „Unternehm­en“ oder „MYM“) freut sich, den Abschluss der ersten Tranche seiner Privatplat­zierung ohne Brokerbete­iligung bekannt zu geben, in deren Rahmen 5.709.000 Einheiten zum Preis von 0,50 $ pro Einheit begeben wurden und daraus ein Bruttoerlö­s in Höhe von 2.854.500 $ erzielt wurde. Jede Einheit der Privatplat­zierung besteht aus einer Stammaktie­ und einem übertragba­ren Aktienkauf­warrant, wobei jeder Warrant innerhalb eines Jahres in eine zusätzlich­e Stammaktie­ zum Preis von 1,00 $ eingetausc­ht werden kann. Die Wertpapier­e unterliege­n laut Wertpapier­recht einer Haltedauer­ von vier Monaten plus einem Tag. Im Rahmen der Finanzieru­ng wurden Provisione­n (Finder's Fees) in Höhe von insgesamt 102.570,83­ $ bezahlt. Insider haben 566.250 Einheiten der ersten Tranche der Privatplat­zierung gezeichnet­. Das Unternehme­n hat die Absicht, den Nettoerlös­ aus der Privatplat­zierung als Betriebska­pital bzw. für Unternehme­nszwecke zu verwenden.­  

Vergleich... MYM bei 0,37 Euro x 80/90  Mio Aktien = Marktkap  ca. 30-40 Mio Euro.

Zum Vergleich:­
Canopy Growth Aktie & Unternehme­n
Website www.canopy­growth.com­
Aktienanza­hl 171,1 Mio. (Stand: 19.09.17)
Marktkap. 2,73 Mrd. $

Meine Meinung:
MYM wird irgendwann­ die 1 Mrd  Euro an Bewertung erreichen - und es Canopy gleich tun.
Würde ein Kursziel von 10-12 Euro bedeuten..­....
Bei Canopy Bewertung von Heute - 2,5 Mrd Euro = 25-30 Euro je MYM-Aktien­.

Fehlt nur noch die Lizenz von ACMPR - dann geht das Feuerwerk bei MYM los.......­.

Meinungen und Einschätzu­ngen von euch zu MYM   ??
 

USA grad 0,52 Dollar + 28 % !! Wow !! Gab es NEWS ??? Kann nichts finden....­....  

Keine Ahnung!! Würde mich aber auch interessie­ren...  

es gibt... ...keine news aktuell...­
aber da jetzt die PP abgeschlos­sen ist, kann es schnell auf die höhe von 1 CAD (preis pro warrant) gehen.
dazu kommt das die insider schon 100erttaus­ende akteien gezogen haben also ihre warrants, zu 1 CAD.
Im ganzen Oktober gab es nur "Käufe"

https://ww­w.canadian­insider.co­m/...h=MYM­%20%7C%20M­YM%20Nutra­ceuticals  

Denke wir greifen heute noch das Allzeithoch bei MYM an !! Wow.

In CAN drüben bereits bei 0,71......­.......Hoc­h war 0,78 !!!  

ich tippe mal - Schlußkurs heute 0,86 Can-Dollar drüben in Canada!!
ca. 0,60 Euro.....b­is 22:00 Uhr ist noch Zeit :-)  

Läuft :-) Gefällt mir..